Back to Journals » Cancer Management and Research » Volume 13

Long Noncoding RNA VPS9D1-AS1 Sequesters microRNA-525-5p to Promote the Oncogenicity of Colorectal Cancer Cells by Upregulating HMGA1 [Expression of Concern]

Authors Liu H, Zhang X, Jin X, Yang Y, Liang G, Ma Y, Wang B

Received 15 October 2021

Accepted for publication 15 October 2021

Published 20 October 2021 Volume 2021:13 Pages 7971—7972

DOI https://doi.org/10.2147/CMAR.S344582



Liu H, Zhang X, Jin X, et al. Cancer Manag Res. 2020;12:9915–9928.

The Editor and Publisher of Cancer Management and Research wish to publish an Expression of Concern for the published article. Following publication, concerns were raised about the scientific integrity of the articles content. We reached out to the authors requesting they supply information that would confirm the integrity of the data. The authors provided several files in response to our queries but they did not satisfy our requirements to confirm the authenticity of some types of data. In addition, there were unexplained similarities between some of the figures presented in this article, and figures presented in articles by different authors groups. As yet, the authors have not provided a satisfactory explanation for this.

Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution.

The authors have been notified about this Expression of Concern.

Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.